• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯丙酮尿症成年患者的血浆胆固醇

Plasma cholesterol in adults with phenylketonuria.

作者信息

Williams Robin A, Hooper Amanda J, Bell Damon A, Mamotte Cyril D S, Burnett John R

机构信息

1Department of Clinical Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital, Perth 2School of Medicine and Pharmacology, University of Western Australia, Perth 3School of Pathology and Laboratory Medicine, University of Western Australia, Perth 4Department of Internal Medicine, Royal Perth Hospital, Perth 5School of Biomedical Science and CHIRI Biosciences Research Precinct, Curtin University, Bentley, WA, Australia.

出版信息

Pathology. 2015 Feb;47(2):134-7. doi: 10.1097/PAT.0000000000000210.

DOI:10.1097/PAT.0000000000000210
PMID:25551302
Abstract

Phenylketonuria (PKU) is an autosomal recessive disorder of phenylalanine (Phe) catabolism resulting from a deficiency of L-phenylalanine hydroxylase (PAH). An association between hyperphenylalaninaemia (HPA) and hypocholesterolaemia has been reported in children. However, controversy exists as to whether this is due to the low protein diet or to a disruption to cholesterol biosynthesis inherent to those with PKU. We investigated the relationship between blood Phe and plasma cholesterol in 41 apparently healthy adults with PKU (26 female, 15 male, age 18-57 years, median age 26 years) attending a PKU outpatient clinic at an adult tertiary care hospital. Of these patients, 33 (80%) were compliant with a Phe-restricted diet with amino acid supplementation, whereas eight (20%) were not. The PKU subjects had a mean body mass index (BMI) of 30.3 ± 1.8 kg/m; 72% were obese, 14% overweight, with only 14% having normal BMI. The mean blood Phe was 1194 ± 522 μmol/L with plasma total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol and apolipoprotein (apo) B concentrations of 4.3 ± 0.8 mmol/L, 1.6 ± 0.8 mmol/L, 1.2 ± 0.3 mmol/L, 2.3 ± 0.8 mmol/L, and 0.83 ± 0.21 g/L, respectively. The mean LDL-cholesterol was 19% lower in PKU females than that of 8944 age-matched females from a community population (2.5 ± 0.8 mmol/L vs. 3.1 ± 0.9 mmol/L, p < 0.001). Similarly, the mean LDL-cholesterol was 32% lower in PKU males than 3786 age-matched males (2.1 ± 0.7 mmol/L vs. 3.1 ± 1.0 mmol/L, p < 0.0001). No correlations were observed between Phe and total cholesterol, LDL-cholesterol or apoB in the PKU cohort. Adults with PKU had low-normal cholesterol concentrations, with no correlation observed between Phe and cholesterol levels. Our findings support the concept that the HPA found in PKU, rather than an effect of a low-protein diet, leads to hypocholesterolaemia. Studies are required to determine whether this cholesterol-lowering effect confers cardioprotection.

摘要

苯丙酮尿症(PKU)是一种常染色体隐性疾病,因缺乏L - 苯丙氨酸羟化酶(PAH)导致苯丙氨酸(Phe)分解代谢紊乱。有报道称儿童中高苯丙氨酸血症(HPA)与低胆固醇血症有关。然而,对于这是由于低蛋白饮食还是PKU患者固有的胆固醇生物合成中断所致,仍存在争议。我们调查了41名在一家成人三级护理医院的PKU门诊就诊的表面健康的成年PKU患者(26名女性,15名男性,年龄18 - 57岁,中位年龄26岁)血液中Phe与血浆胆固醇之间的关系。这些患者中,33名(80%)遵循限制Phe饮食并补充氨基酸,而8名(20%)未遵循。PKU受试者的平均体重指数(BMI)为30.3±1.8kg/m²;72%肥胖,14%超重,只有14%的BMI正常。平均血液Phe为1194±522μmol/L,血浆总胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇和载脂蛋白(apo)B浓度分别为4.3±0.8mmol/L、1.6±0.8mmol/L、1.2±0.3mmol/L、2.3±0.8mmol/L和0.83±0.21g/L。PKU女性的平均低密度脂蛋白胆固醇比来自社区人群的8944名年龄匹配女性低19%(2.5±0.8mmol/L对3.1±0.9mmol/L,p<0.001)。同样,PKU男性的平均低密度脂蛋白胆固醇比3786名年龄匹配男性低32%(2.1±0.7mmol/L对3.1±1.0mmol/L,p<0.0001)。在PKU队列中,未观察到Phe与总胆固醇、低密度脂蛋白胆固醇或apoB之间的相关性。成年PKU患者的胆固醇浓度处于略低正常水平,未观察到Phe与胆固醇水平之间的相关性。我们的研究结果支持这样的概念,即PKU中发现的HPA而非低蛋白饮食的影响导致低胆固醇血症。需要进行研究以确定这种降胆固醇作用是否具有心脏保护作用。

相似文献

1
Plasma cholesterol in adults with phenylketonuria.苯丙酮尿症成年患者的血浆胆固醇
Pathology. 2015 Feb;47(2):134-7. doi: 10.1097/PAT.0000000000000210.
2
Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.高苯丙氨酸血症患者的血脂状况及其他相关因素
Orphanet J Rare Dis. 2016 Sep 9;11(1):123. doi: 10.1186/s13023-016-0508-x.
3
Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?2012 年至 2018 年期间欧洲苯丙酮尿症患者的血苯丙氨酸水平:是否正在发生变化?
Nutrients. 2024 Jun 28;16(13):2064. doi: 10.3390/nu16132064.
4
Blood-brain phenylalanine relationships in persons with phenylketonuria.苯丙酮尿症患者血液与大脑中苯丙氨酸的关系。
Pediatrics. 2000 Nov;106(5):1093-6. doi: 10.1542/peds.106.5.1093.
5
Changes of lipoproteins in phenylalanine hydroxylase-deficient children during the first year of life.苯丙氨酸羟化酶缺乏儿童出生后第一年脂蛋白的变化
Clin Chim Acta. 2014 Jun 10;433:1-4. doi: 10.1016/j.cca.2014.02.020. Epub 2014 Mar 5.
6
Optimized loading test to evaluate responsiveness to tetrahydrobiopterin (BH4) in Brazilian patients with phenylalanine hydroxylase deficiency.优化负荷试验评估巴西苯丙氨酸羟化酶缺乏症患者对四氢生物蝶呤(BH4)的反应性。
Mol Genet Metab. 2011;104 Suppl:S80-5. doi: 10.1016/j.ymgme.2011.09.019. Epub 2011 Sep 20.
7
L-Phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods.苯丙酮尿症患者血液中 L-苯丙氨酸浓度:改良酶比色法与氨基酸分析、串联质谱法和 HPLC 法的比较。
Clin Chem Lab Med. 2010 Sep;48(9):1271-9. doi: 10.1515/CCLM.2010.271.
8
Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.采用低苯丙氨酸饮食的早治疗苯丙酮尿症儿童、青少年及青年成人的肉碱状况
Ann Nutr Metab. 2008;53(2):91-5. doi: 10.1159/000165356. Epub 2008 Oct 22.
9
Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation.与健康对照组相比,成年苯丙酮尿症(PKU)患者的血浆胆固醇、LDL-胆固醇和 LDL 脂蛋白亚类降低:NMR 代谢组学研究结果。
Orphanet J Rare Dis. 2020 Feb 27;15(1):61. doi: 10.1186/s13023-020-1329-5.
10
Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.四氢生物蝶呤在治疗母体苯丙酮尿症中的潜在作用。
Pediatrics. 2003 Dec;112(6 Pt 2):1566-9.

引用本文的文献

1
The association of plasma level of phenylalanine with inflammatory markers, insulin resistance, and atherosclerotic indexes in patients with phenylketonuria.苯丙酮尿症患者血浆苯丙氨酸水平与炎症标志物、胰岛素抵抗及动脉粥样硬化指标的相关性
J Diabetes Metab Disord. 2025 May 14;24(1):119. doi: 10.1007/s40200-025-01631-7. eCollection 2025 Jun.
2
The relationship between adult phenylketonuria and the cardiovascular system - insights into mechanisms and risks.成人苯丙酮尿症与心血管系统的关系——对机制和风险的见解
Orphanet J Rare Dis. 2025 Apr 2;20(1):156. doi: 10.1186/s13023-025-03686-4.
3
Overweight and obesity in adult patients with phenylketonuria: a systematic review.
成人苯丙酮尿症患者超重和肥胖:系统评价。
Orphanet J Rare Dis. 2023 Feb 22;18(1):37. doi: 10.1186/s13023-023-02636-2.
4
Dietetic Management of Adults with Phenylketonuria (PKU) in the UK: A Care Consensus Document.英国成人苯丙酮尿症(PKU)患者的饮食管理:护理共识文件。
Nutrients. 2022 Jan 28;14(3):576. doi: 10.3390/nu14030576.
5
CRISPR/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria.CRISPR/Cas9 基因敲除敲除苯丙氨酸羟化酶蛋白的小鼠作为人类苯丙酮尿症的新型临床前模型。
Sci Rep. 2021 Mar 31;11(1):7254. doi: 10.1038/s41598-021-86663-8.
6
Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data.苯丙酮尿症(PKU)患者的临床疾病负担及相关合并症 - 德国健康保险索赔数据的回顾性研究。
Orphanet J Rare Dis. 2019 Jul 22;14(1):181. doi: 10.1186/s13023-019-1153-y.